MaxCyte, Inc.
MXCT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $38,627 | $41,288 | $44,261 | $33,894 |
| % Growth | -6.4% | -6.7% | 30.6% | – |
| Cost of Goods Sold | $7,100 | $4,742 | $5,098 | $3,647 |
| Gross Profit | $31,527 | $36,546 | $39,163 | $30,247 |
| % Margin | 81.6% | 88.5% | 88.5% | 89.2% |
| R&D Expenses | $22,227 | $23,817 | $19,514 | $15,407 |
| G&A Expenses | $29,693 | $30,068 | $25,829 | $18,676 |
| SG&A Expenses | $56,354 | $57,043 | $44,482 | $31,679 |
| Sales & Mktg Exp. | $26,661 | $26,975 | $18,653 | $13,003 |
| Other Operating Expenses | $4,143 | $3,985 | $2,528 | $1,349 |
| Operating Expenses | $82,724 | $84,845 | $66,524 | $48,435 |
| Operating Income | -$51,197 | -$48,299 | -$27,361 | -$18,189 |
| % Margin | -132.5% | -117% | -61.8% | -53.7% |
| Other Income/Exp. Net | $10,142 | $10,376 | $3,790 | -$894 |
| Pre-Tax Income | -$41,055 | -$37,923 | -$23,571 | -$19,082 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$41,055 | -$37,923 | -$23,571 | -$19,082 |
| % Margin | -106.3% | -91.8% | -53.3% | -56.3% |
| EPS | -0.39 | -0.37 | -0.19 | -0.22 |
| % Growth | -5.4% | -94.7% | 13.6% | – |
| EPS Diluted | -0.39 | -0.37 | -0.19 | -0.22 |
| Weighted Avg Shares Out | 104,849 | 103,269 | 101,703 | 90,619 |
| Weighted Avg Shares Out Dil | 104,849 | 103,269 | 101,703 | 90,619 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10,142 | $10,376 | $3,917 | $151 |
| Interest Expense | $0 | $0 | $127 | $1,044 |
| Depreciation & Amortization | $4,790 | $4,171 | $2,698 | $1,424 |
| EBITDA | -$46,407 | -$44,128 | -$24,663 | -$16,614 |
| % Margin | -120.1% | -106.9% | -55.7% | -49% |